Загрузка...
Structure of the Complex of Human Programmed Death 1, PD-1, and Its Ligand PD-L1
Targeting the PD-1/PD-L1 immunologic checkpoint with monoclonal antibodies has recently provided breakthrough progress in the treatment of melanoma, non-small cell lung cancer, and other types of cancer. Small-molecule drugs interfering with this pathway are highly awaited, but their development is...
Сохранить в:
| Опубликовано в: : | Structure |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4752817/ https://ncbi.nlm.nih.gov/pubmed/26602187 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.str.2015.09.010 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|